|
Symbol
|
P322TQ | WEVLTQ | WXNLTQ | EOJRCH | RMABXV | YOTLTQ | RMBWDV | RMAVSV | RMAXKV | BTJBKB | ZPRLTQ | OCGRCH | LTHCLK | RMBE8V | AAIETQ | OVCRCH | AAXSTQ | OZURCH | PBVRCH | RMA3QV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Multi Vonti | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti |
|
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS / UBS / Zurich | Holcim/Amrize Basket / Kühne & Nagel Intl. AG / Nestlé S.A. / Novartis AG / Roche AG | Holcim/Amrize Basket / Nestlé S.A. / Novartis AG / Swiss RE AG / Zurich Insurance Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | ABB N / Nestlé N / Novartis N / Roche GS / Swiss RE AG | Nestlé / Novartis | Nestlé / Novartis / Roche GS | Novartis AG / Sandoz Group AG / Straumann Hldg. AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Geberit AG / Nestlé S.A. / Novartis AG / UBS Group AG / Zurich Insurance Group AG | ABB / Nestlé / Novartis / Roche GS / Zurich | Alcon / Lonza Group N / Novartis AG / Roche AG / Sandoz Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
23.12.2025 | 31.03.2028 | 30.06.2028 | 14.01.2026 | 12.10.2026 | 24.11.2027 | 27.07.2026 | 23.02.2026 | 23.03.2026 | 08.04.2027 | 23.04.2027 | 26.04.2027 | 09.07.2027 | 13.07.2026 | 19.07.2027 | 09.06.2026 | 13.09.2027 | 07.07.2026 | 21.04.2027 | 09.11.2026 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
80,46 | 167,96 | 179,73 | 188,09 | 182,96 | 178,20 | 63,33 | 68,01 | 79,63 | 47,875 | 45,96 | 58,5776 | 31,6224 | 83,70 | 140,14 | 76,59 | 43,77 | 70,5096 | 66,6248 | 56,14 |
| rendement max. p.a. | 125,53% | 5,31% | 6,81% | -0,43% | 10,28% | 6,26% | 4,51% | 70,98% | 3,99% | 3,80% | 3,16% | 4,39% | 5,32% | 21,50% | 1,39% | 20,26% | 3,04% | 4,69% | 4,43% | 7,58% |
| Demande | 98,11 | 100,27 | 93,87 | 100,51 | 95,40 | 95,81 | 99,90 | 79,00 | 100,00 | - | 103,18 | - | - | 91,40 | - | - | 101,24 | 100,36 | - | 97,10 |
| Offre | 98,91 | 101,08 | 94,67 | 101,32 | 96,20 | 96,61 | 100,90 | 86,00 | 101,00 | - | 104,01 | - | - | 92,40 | - | - | 102,05 | 101,17 | - | 98,10 |